Quick Answer
Immunome Inc. reported Earnings Per Share Diluted of $2.43 (loss) per share for the year ending 2025.
- Immunome Inc. showed an increase of +51.4% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Immunome Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), Immunome Inc.'s Earnings Per Share Diluted has grown by 53.8%.
- Historical annual values: Fiscal year 2025: $2.43 (loss) per share | Fiscal year 2024: $5.00 (loss) per share | Fiscal year 2023: $5.38 (loss) per share | Fiscal year 2022: $3.09 (loss) per share | Fiscal year 2021: $2.14 (loss) per share | Fiscal year 2020: $5.26 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: